Results 91 to 100 of about 41,075 (183)

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study

Journal of Inflammation Research, 2022
José Javier Morales-Núñez,1 Mariel García-Chagollán,1 José Francisco Muñoz-Valle,1 Saúl Alberto Díaz-Pérez,1 Paola Carolina Torres-Hernández,2 Saraí Citlalic Rodríguez-Reyes,3 Guillermo Santoscoy-Ascencio,4 José Julio Sierra García de Quevedo,4 Jorge ...
Morales-Núñez JJ, García-Chagollán M, Muñoz-Valle JF, Díaz-Pérez SA, Torres-Hernández PC, Rodríguez-Reyes SC, Santoscoy-Ascencio G, Sierra García de Quevedo JJ, Hernández-Bello J   +8 more
doaj  

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. [PDF]

, 2021
BACKGROUND: The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We aimed to investigate the safety and effectiveness of these vaccines in a UK community
Antonelli, M, Canas, LS, Capdevila, J, Chan, AT, Drew, DA, Goodman, AL, Graham, MS, Hammers, A, Hu, C, Joshi, AD, Klaser, K, Louca, P, Mangino, M, May, A, Menni, C, Merino, J, Modat, M, Molteni, E, Murray, B, Nguyen, LH, Ourselin, S, Polidori, L, Selvachandran, S, Spector, TD, Steves, CJ, Sudre, CH, Valdes, AM, Wolf, J   +27 more
core  

Mass‐Standardised Differential Antibody Binding to a Spectrum of SARS‐CoV‐2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 Variants—Antibody Immunity Endotypes

Immunology, Volume 177, Issue 4, Page 798-809, April 2026.
Fully quantitative, mass‐standardised, antibody responses to ten SARS‐CoV‐2 variants show significant variation in immunity profiles or endotypes. The incidence of the complete response to all variants is significantly improved after three vaccinations.
Philip H. James‐Pemberton, Shivali Kohli, Jordan Twynham, Aaron C. Westlake, Alex Antill, Rouslan V. Olkhov, Andrew M. Shaw   +6 more
wiley   +1 more source

COVID‐19 and Pregnancy: Key Findings

Scandinavian Journal of Immunology, Volume 103, Issue 4, April 2026.
Mechanistic overview of maternal SARS‐CoV‐2 immunisation, affinity‐matured IgG production, FcRn‐mediated transplacental IgG transport, and antibody delivery to the newborn via fetal circulation and breast milk. The schematic also highlights the translational relevance of murine models, which share conserved mechanisms of antibody induction despite ...
Gabrielle Gimenes Lima, Ana Flávia Segati, Giovanna Santos Oliveira, Nicoly Simões de Melo, Túlio Nakazato da Cunha, Elizabeth De Gaspari   +5 more
wiley   +1 more source

Potent and Long‐Lasting Immunogenicity Generated by LNP‐mRNA gE Antigen Against Varicella Zoster Virus via an AI‐Assisted Pipeline

Advanced Science, Volume 13, Issue 14, 9 March 2026.
This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Kai Dong, Fang Liu, Dawei Wang, Yanfen Li, Man Zhang, Yuting Zhou, Gengshen Song   +6 more
wiley   +1 more source

Critical Evaluation of the Impact of COVID‐19 Pandemic on Child Health and Wellbeing and Suggested Preparedness for Future Pandemics–A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims The immediate and long‐term effects of COVID‐19 pandemic on the children go beyond just being a viral infection. A child's mental health and psychological issues like irritability, anxiety, sadness, non‐attentiveness, attention deficit and hyperactive disorder needed evaluation.
Ranjan K. Mohapatra, Ashish K. Sarangi, Gurudutta Pattnaik, Puneet K. Singh, Rasmita Dash, Venkataramana Kandi, L. V. Simhachalam Kutikuppala, Rudra Narayan Sahoo, Snehasish Mishra, Anita Mishra, Sourya Subhra Nasker, Sasmita Nayak, Hayam A. Alrasheed, Nawal A. Al Kaabi, Amer Alshengeti, Altaf A. Abdulkhaliq, Ali A. Rabaan, Maha F. Al‐Subaie, Saad Alhumaid, Kuldeep Dhama, Md. Kudrat‐E‐Zahan   +20 more
wiley   +1 more source

Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study. [PDF]

, 2023
Alagoz S., Cebeci E., Eren N., et al., Kazancioglu R., Mirioglu S., Sakaci T., Seyahi N., Sumbul B., Tugcu M., Tuglular S.   +10 more
core   +2 more sources

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes [PDF]

, 2022
Abdul-Jawad, Sultan, Alaguthurai, Thanussuyah, Beatson, Richard, Doores, Katie J, Graham, Carl, Graham, Rosalind, Irshad, Sheeba, Kulasekararaj, Austin, Lechmere, Thomas, Patten, Piers Em, Vidler, Jennifer   +10 more
core   +4 more sources

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Turkish Journal of Hematology, 2022
Tekin Guney, Ferda Can, Sema Akıncı, Özge Soyer Kösemehmetoğlu, İmdat Dilek   +4 more
doaj   +1 more source

Drug Product Development of Lipid Nanoparticle‐Based mRNA Therapeutics and Vaccines

WIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.
Overview of the development path from an mRNA–lipid nanoparticle (LNP) concept to a licensed drug product, covering LNP design, manufacturing process development, formulation, and analytical characterization. ABSTRACT Lipid nanoparticles (LNP) are currently the most relevant non‐viral delivery systems for mRNA and occasionally for smaller nucleic acids
Gideon Kersten, Eleonora Cerasoli, Bruce Kerwin, Olivia M. Merkel, Andrea Hawe   +4 more
wiley   +1 more source